207 related articles for article (PubMed ID: 37038975)
21. Angiotensin II activates Ca
Kashihara T; Nakada T; Kojima K; Takeshita T; Yamada M
J Physiol; 2017 Jul; 595(13):4207-4225. PubMed ID: 28295363
[TBL] [Abstract][Full Text] [Related]
22. Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias.
Kawakami K; Yanagawa M; Hiratsuka S; Yoshida M; Ono Y; Hiroshima M; Ueda M; Aoki J; Sako Y; Inoue A
Nat Commun; 2022 Jan; 13(1):487. PubMed ID: 35078997
[TBL] [Abstract][Full Text] [Related]
23. Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology.
Braga Emidio N; Small BM; Keller AR; Cheloha RW; Wingler LM
Mol Pharmacol; 2024 Feb; 105(3):260-271. PubMed ID: 38164609
[TBL] [Abstract][Full Text] [Related]
24. Comparative analyses of downstream signal transduction targets modulated after activation of the AT1 receptor by two β-arrestin-biased agonists.
Santos GA; Duarte DA; Parreiras-E-Silva LT; Teixeira FR; Silva-Rocha R; Oliveira EB; Bouvier M; Costa-Neto CM
Front Pharmacol; 2015; 6():131. PubMed ID: 26191004
[TBL] [Abstract][Full Text] [Related]
25. Myogenic Vasoconstriction Requires Canonical G
Cui Y; Kassmann M; Nickel S; Zhang C; Alenina N; Anistan YM; Schleifenbaum J; Bader M; Welsh DG; Huang Y; Gollasch M
J Am Heart Assoc; 2022 Feb; 11(4):e022070. PubMed ID: 35132870
[TBL] [Abstract][Full Text] [Related]
26. The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling network.
Kendall RT; Strungs EG; Rachidi SM; Lee MH; El-Shewy HM; Luttrell DK; Janech MG; Luttrell LM
J Biol Chem; 2011 Jun; 286(22):19880-91. PubMed ID: 21502318
[TBL] [Abstract][Full Text] [Related]
27. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
[TBL] [Abstract][Full Text] [Related]
28. Label-free cell signaling pathway deconvolution of angiotensin type 1 receptor reveals time-resolved G-protein activity and distinct AngII and AngIIIIV responses.
Lavenus S; Simard É; Besserer-Offroy É; Froehlich U; Leduc R; Grandbois M
Pharmacol Res; 2018 Oct; 136():108-120. PubMed ID: 29959993
[TBL] [Abstract][Full Text] [Related]
29. Differential beta-arrestin binding of AT1 and AT2 angiotensin receptors.
Turu G; Szidonya L; Gáborik Z; Buday L; Spät A; Clark AJ; Hunyady L
FEBS Lett; 2006 Jan; 580(1):41-5. PubMed ID: 16359671
[TBL] [Abstract][Full Text] [Related]
30. Insights Into the Role of Angiotensin-II AT
Mathieu NM; Nakagawa P; Grobe JL; Sigmund CD
Hypertension; 2024 Jan; 81(1):6-16. PubMed ID: 37449411
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
[TBL] [Abstract][Full Text] [Related]
32. Biased agonism of the angiotensin II type 1 receptor.
Godin CM; Ferguson SS
Mini Rev Med Chem; 2012 Aug; 12(9):812-6. PubMed ID: 22681254
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of angiotensin II receptor internalization.
Hunyady L
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S47-56. PubMed ID: 9892140
[TBL] [Abstract][Full Text] [Related]
34. The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor.
Turu G; Balla A; Hunyady L
Front Endocrinol (Lausanne); 2019; 10():519. PubMed ID: 31447777
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations.
Wingler LM; Elgeti M; Hilger D; Latorraca NR; Lerch MT; Staus DP; Dror RO; Kobilka BK; Hubbell WL; Lefkowitz RJ
Cell; 2019 Jan; 176(3):468-478.e11. PubMed ID: 30639099
[TBL] [Abstract][Full Text] [Related]
36. Troglitazone stimulates beta-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor.
Tilley DG; Nguyen AD; Rockman HA
Biochem Biophys Res Commun; 2010 Jun; 396(4):921-6. PubMed ID: 20460106
[TBL] [Abstract][Full Text] [Related]
37. Cartilage oligomeric matrix protein is an endogenous β-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury.
Fu Y; Huang Y; Yang Z; Chen Y; Zheng J; Mao C; Li Z; Liu Z; Yu B; Li T; Wang M; Xu C; Zhou Y; Zhao G; Jia Y; Guo W; Jia X; Zhang T; Li L; Liu Z; Guo S; Ma M; Zhang H; Liu B; Du J; Wang W; Tang C; Gao P; Xu Q; Wang X; Liu J; Sun J; Kong W
Cell Res; 2021 Jul; 31(7):773-790. PubMed ID: 33510386
[TBL] [Abstract][Full Text] [Related]
38. Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.
Bonde MM; Hansen JT; Sanni SJ; Haunsø S; Gammeltoft S; Lyngsø C; Hansen JL
PLoS One; 2010 Nov; 5(11):e14135. PubMed ID: 21152433
[TBL] [Abstract][Full Text] [Related]
39. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor.
Chen J; Liu J; Yuan Y; Chen X; Zhang F; Pu X
J Chem Inf Model; 2022 Nov; 62(21):5175-5192. PubMed ID: 34802238
[TBL] [Abstract][Full Text] [Related]
40. Single-molecule force spectroscopy study of interactions between angiotensin II type 1 receptor and different biased ligands in living cells.
Li W; Xu J; Kou X; Zhao R; Zhou W; Fang X
Anal Bioanal Chem; 2018 May; 410(14):3275-3284. PubMed ID: 29492619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
